Kodiak Sciences (KOD) awards CEO Perlroth 100,000 stock options

Rhea-AI Filing Summary

Kodiak Sciences Inc. reported that Chairman, CEO and 10% owner Victor Perlroth received a grant of stock options covering 100,000.0000 shares of Common Stock at an exercise price of $42.4200 per share. These options expire on 2036-07-14 and vest monthly beginning after July 1, 2026, subject to his Continuous Service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider PERLROTH VICTOR

Role Chairman and CEO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	100,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 100,000 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Stock options granted: 100000.0000 shares Exercise price: $42.4200 per share Option expiration date: 2036-07-14 +3 more

6 metrics

Stock options granted 100000.0000 shares Stock Option (Right to Buy) awarded to Victor Perlroth on 2026-07-15

Exercise price $42.4200 per share Conversion or exercise price for the reported stock option grant

Option expiration date 2036-07-14 Expiration date of the Stock Option (Right to Buy)

Total option shares after transaction 100000.0000 Total derivative shares held following the grant

Initial vesting fraction 1/48 Portion of shares that vest one month after July 1, 2026

Monthly vesting installments 47 Number of successive equal monthly installments after the initial vesting

Key Terms

Stock Option (Right to Buy), Continuous Service, 2018 Equity Incentive Plan, vesting

4 terms

Stock Option (Right to Buy) financial

"security_title shows "Stock Option (Right to Buy)" for the grant"

Continuous Service financial

"subject to the Reporting Person's Continuous Service as of each vesting date"

2018 Equity Incentive Plan financial

"Continuous Service (as defined in the 2018 Equity Incentive Plan)"

vesting financial

"shares vest one month after July 1, 2026; the balance of the shares vest"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/17/2026 - 04:39 PM Accepted by SEC EDGAR 07/17/2026 - 04:38 PM Learn about SEC filing dates

FAQ

What insider transaction did Kodiak Sciences (KOD) report for Victor Perlroth?

Kodiak Sciences reported a stock option grant to Chairman and CEO Victor Perlroth for 100,000.0000 shares of Common Stock. The options have a $42.4200 exercise price and expire on 2036-07-14, providing long-term equity-based compensation.

What is the exercise price and expiration date of the new Kodiak Sciences (KOD) options?

The granted options carry an exercise price of $42.4200 per share and expire on 2036-07-14. This defines the price at which Perlroth may buy Kodiak Sciences Common Stock and the latest date by which the options must be exercised.

How do the Victor Perlroth stock options at Kodiak Sciences (KOD) vest?

The options vest over time: 1/48th of the shares vest one month after July 1, 2026, and the remaining shares vest in 47 successive equal monthly installments. Vesting is conditioned on Perlroth’s Continuous Service under the 2018 Equity Incentive Plan.

How many Kodiak Sciences (KOD) option shares does Victor Perlroth hold after this grant?

Following this transaction, Victor Perlroth holds 100,000.0000 option shares tied to this grant. The filing lists these as Stock Options (Right to Buy) with underlying Common Stock, all reported as direct ownership on the Form 4.

Under which plan were the new Kodiak Sciences (KOD) options for Victor Perlroth granted?

The vesting conditions reference the company’s 2018 Equity Incentive Plan. Continuous Service is defined under this plan, and Perlroth’s ongoing service with Kodiak Sciences must continue through each vesting date for the related option shares to vest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PERLROTH VICTOR

(Last) (First) (Middle)

1250 PAGE MILL ROAD

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Kodiak Sciences Inc. [ KOD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$42.42	07/15/2026		A		100,000		(1)	07/14/2036	Common Stock	100,000	$0	100,000	D

Explanation of Responses:

1. One-forty-eighth (1/48th) of the shares vest one month after July 1, 2026; the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 Equity Incentive Plan) as of each vesting date.

	/s/ David Peinsipp, Attorney-in-Fact for Victor Perlroth	07/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)